USPTO serial 79349530
NEURIMMUNE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 21, 2023
- Examiner
- LEASER, ANDREW C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEURIMMUNE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
Janice Housey Litmus Law PLLC4 Weems Lane #240Winchester, VA 22601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine and metabolic diseases, circulatory system diseases, eye diseases; veterinary preparations for the treatment of nervous system diseases, infectious diseases, neoplasms, immune system diseases, endocrine diseases, metabolic diseases, circulatory system diseases, eye diseases; pharmaceutical preparations for immunotherapeutic use, pharmaceutical agents for the elimination of tumors, pharmaceutical preparations for the treatment of neurodegenerative diseases, pharmaceutical preparations, namely, immunogens; pharmaceutical preparations, namely, antibodies used for the testing of the disease; vaccines; diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; pharmaceutical preparations, namely, synthetic peptides used for the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical or veterinary use; sanitary towels for hygiene purposes; dietetic foods for medical use; dietetic beverages for medical use; biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseases, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunological diseases, inflammatory diseases, respiratory diseases, psychological diseases; anti-bacterial preparations, namely, antibacterial substances for medical use, anti-bacterial pharmaceutical preparations, bio-pharmaceutical preparations for the treatment of cancer; protein food supplements | ACTIVE | — |
| 042 | Monitoring, inspection and analysis of biologically active chemicals for quality control purposes; research in the field of pharmaceutical products, cosmetics and foodstuffs for others; advisory and information services in the field of monitoring and inspection for the quality control and scientific analysis of biologically active chemicals; research in the field of medical treatment and medical methods; research in the field of biotechnology and antibodies; medical and scientific research in the field of clinical trial review and research with regard to medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; software design; computer programming; software maintenance; design and development of computer hardware; software development; consultancy and providing of information with respect to quality control of pharmaceutical products; scientific research in the field of cancerous diseases; scientific research with respect to chemistry | ACTIVE | — |
| 044 | Medical services; medical services in the field of immunity; providing medical information; medical examinations, namely, physical examinations for medical purposes; pharmaceutical consulting related to the compounding of medicines; wellness and health-related consulting services in the fields of nutrition and diet; consultancy and providing of information in the field of sanitary care, namely, providing of health information in connection with health; veterinary services; beauty salon services; animal care services, namely, veterinary care services; medical consulting services for hygiene in the field of care; medical consultancy and providing of medical information with respect to preparation, administration and dosing of pharmaceutical preparations; medical and pharmaceutical consulting services relating to the preparation of pharmaceutical prescriptions by pharmacists and administration of pharmaceuticals; providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnostic, prophylactic and therapeutic properties of medicines; drug testing, namely, systematic testing of medicinal products for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks owned by Neurimmune Holding AG
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NEURIMMUNE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 12, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 12, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 18, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 26, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 26, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 5, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 5, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 16, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 16, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 16, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 2, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 8, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 18, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 4, 2023 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Nov 4, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 16, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 7, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 7, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 7, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 7, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 20, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |